Interferon alfa

Janessa Smith, Pharm.D. BCPS, Paul A. Pham, Pharm.D.
Interferon alfa is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Interferon [IFN] alfa 2a and IFN alfa 2b: Hepatitis C (not recommended) and AIDS-related KS,
  • IFN alfa 2a: CML and hairy cell leukemia
  • IFN alfa 2b: Hepatitis B, condyloma acuminata, hairy cell leukemia, malignant melanoma, follicular lymphoma
  • Pegylated IFN alfa 2a: Hepatitis C including treatment of HCV-HIV coinfected pts (Pegasys and Copegus)

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Interferon [IFN] alfa 2a and IFN alfa 2b: Hepatitis C (not recommended) and AIDS-related KS,
  • IFN alfa 2a: CML and hairy cell leukemia
  • IFN alfa 2b: Hepatitis B, condyloma acuminata, hairy cell leukemia, malignant melanoma, follicular lymphoma
  • Pegylated IFN alfa 2a: Hepatitis C including treatment of HCV-HIV coinfected pts (Pegasys and Copegus)

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: December 11, 2017